Emerald Advisers’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Emerald Advisers’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-683,642	Closed	-$22.8M	–	280
2024 Q3	$22.8M	Buy	683,642 +455,119	+199%	+$15.7M	0.88%	48
2024 Q2	$6.18M	Buy	+228,523	New	+$4.51M	0.26%	106

Emerald Advisers's LBPH Position: Q4 2024 in Review

Emerald Advisers sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 683,642 shares — an estimated $22.8M sold.

Emerald Advisers first reported a position in LBPH in Q2 2024 and held it in 2 quarters. The position peaked at $22.8M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Emerald Advisers reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Emerald Advisers sold 683,642 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $22.8M.
Emerald Advisers first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
Emerald Advisers's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $22.8M in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Emerald Advisers's 13F filing for Q4 2024, filed 11 Feb 2025.